164 related articles for article (PubMed ID: 9169177)
1. Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group.
Mocroft AJ; Lundgren JD; d'Armino Monforte A; Ledergerber B; Barton SE; Vella S; Katlama C; Gerstoft J; Pedersen C; Phillips AN
Int J Epidemiol; 1997 Apr; 26(2):400-7. PubMed ID: 9169177
[TBL] [Abstract][Full Text] [Related]
2. Survival of European patients with Kaposi's sarcoma as AIDS-defining condition during the first decade of AIDS. AIDS in Europe Study Group.
Hermans P; Lundgren J; Sommereijns B; Katlama C; Chiesi A; Goebel FD; Gonzales-Lahoz J; Proenza R; Barton SE; Pedersen C; Clumeck N
AIDS; 1997 Mar; 11(4):525-31. PubMed ID: 9084801
[TBL] [Abstract][Full Text] [Related]
3. The role of initial AIDS-defining illness in survival following AIDS.
Luo K; Law M; Kaldor JM; McDonald AM; Cooper DA
AIDS; 1995 Jan; 9(1):57-63. PubMed ID: 7893442
[TBL] [Abstract][Full Text] [Related]
4. Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991.
Jacobson LP; Kirby AJ; Polk S; Phair JP; Besley DR; Saah AJ; Kingsley LA; Schrager LK
Am J Epidemiol; 1993 Dec; 138(11):952-64. PubMed ID: 7903022
[TBL] [Abstract][Full Text] [Related]
5. Mortality Risk After AIDS-Defining Opportunistic Illness Among HIV-Infected Persons--San Francisco, 1981-2012.
Djawe K; Buchacz K; Hsu L; Chen MJ; Selik RM; Rose C; Williams T; Brooks JT; Schwarcz S
J Infect Dis; 2015 Nov; 212(9):1366-75. PubMed ID: 26044289
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival.
Levine AM; Sullivan-Halley J; Pike MC; Rarick MU; Loureiro C; Bernstein-Singer M; Willson E; Brynes R; Parker J; Rasheed S
Cancer; 1991 Dec; 68(11):2466-72. PubMed ID: 1933784
[TBL] [Abstract][Full Text] [Related]
7. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.
; Mocroft A; Sterne JA; Egger M; May M; Grabar S; Furrer H; Sabin C; Fatkenheuer G; Justice A; Reiss P; d'Arminio Monforte A; Gill J; Hogg R; Bonnet F; Kitahata M; Staszewski S; Casabona J; Harris R; Saag M
Clin Infect Dis; 2009 Apr; 48(8):1138-51. PubMed ID: 19275498
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma and central nervous system disease: a real association or an artifact of the control group? Terry Beirn Community Programs for Clinical Research on AIDS.
Eberly LE; Ohman PA; Neaton JD; Price RW; Abrams DI
AIDS; 2000 May; 14(8):995-1000. PubMed ID: 10853981
[TBL] [Abstract][Full Text] [Related]
9. Impact of opportunistic disease on survival in patients with HIV infection.
Chaisson RE; Gallant JE; Keruly JC; Moore RD
AIDS; 1998 Jan; 12(1):29-33. PubMed ID: 9456252
[TBL] [Abstract][Full Text] [Related]
10. A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy.
Stebbing J; Sanitt A; Nelson M; Powles T; Gazzard B; Bower M
Lancet; 2006 May; 367(9521):1495-502. PubMed ID: 16679162
[TBL] [Abstract][Full Text] [Related]
11. Survival by AIDS defining condition in rural Uganda.
Morgan D; Malamba SS; Orem J; Mayanja B; Okongo M; Whitworth JA
Sex Transm Infect; 2000 Jun; 76(3):193-7. PubMed ID: 10961197
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with survival following secondary AIDS: 1988 to 1995.
Huang H; Chmiel JS; Detels R; Hoover DR; Muñoz A
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):495-504. PubMed ID: 9715847
[TBL] [Abstract][Full Text] [Related]
13. [AIDS and injecting drug use: survival determinants in the highly active antiretroviral therapy era].
Zucchetto A; Bruzzone S; De Paoli A; Regine V; Pappagallo M; Dal Maso L; Serraino D; Rezza G; Suligoi B
Epidemiol Prev; 2009; 33(4-5):184-9. PubMed ID: 20124634
[TBL] [Abstract][Full Text] [Related]
14. Differential impact of combined antiretroviral therapy on the survival of italian patients with specific AIDS-defining illnesses.
Conti S; Masocco M; Pezzotti P; Toccaceli V; Vichi M; Boros S; Urciuoli R; Valdarchi C; Rezza G
J Acquir Immune Defic Syndr; 2000 Dec; 25(5):451-8. PubMed ID: 11141245
[TBL] [Abstract][Full Text] [Related]
15. Survival after diagnosis of AIDS: a prospective observational study of 2625 patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.
Mocroft A; Youle M; Morcinek J; Sabin CA; Gazzard B; Johnson MA; Phillips AN
BMJ; 1997 Feb; 314(7078):409-13. PubMed ID: 9040386
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of AIDS-related Kaposi's sarcoma in Europe over 10 years. AIDS in Europe Study Group.
Hermans P; Lundgren J; Sommereijns B; Pedersen C; Vella S; Katlama C; Lüthy R; Pinching AJ; Gerstoft J; Pehrson P; Clumeck N
AIDS; 1996 Jul; 10(8):911-7. PubMed ID: 8828749
[TBL] [Abstract][Full Text] [Related]
17. HIV positive patients first presenting with an AIDS defining illness: characteristics and survival.
Poznansky MC; Coker R; Skinner C; Hill A; Bailey S; Whitaker L; Renton A; Weber J
BMJ; 1995 Jul; 311(6998):156-8. PubMed ID: 7613426
[TBL] [Abstract][Full Text] [Related]
18. Factors predictive of disease progression and death in AIDS-related Kaposi's sarcoma.
Spano JP; Salhi Y; Costagliola D; Rozenbaum W; Girard PM
HIV Med; 2000 Oct; 1(4):232-7. PubMed ID: 11737354
[TBL] [Abstract][Full Text] [Related]
19. Staging system for clinical AIDS patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.
Mocroft AJ; Johnson MA; Sabin CA; Lipman M; Elford J; Emery V; Morcinek J; Youle M; Janossy G; Lee CA
Lancet; 1995 Jul; 346(8966):12-7. PubMed ID: 7603137
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of Kaposi's sarcoma as an initial and later AIDS associated illness.
Padiglione A; Goldstein D; Law MG; Hoy JF; Kaldor JM; Mijch AM
Ann Oncol; 1997 Sep; 8(9):871-5. PubMed ID: 9358937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
